Name: European Research Ranking: Statistics for: PATHOFINDER B V - Netherlands
Published: 2012-01-01

Ranking results:

Past rankings:

2014
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2012
Criterium:	Position:
Overall Score:	900-1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2026-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2015	50.000	0	50.000	1
2014	0	5.682.351	468.893		1
2012	0	2.876.300	499.000		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
ADENIUM BIOTECH APS	1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES	1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE	1
CORIS BIOCONCEPT SPRL	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
EUROPEAN RESEARCH AND PROJECT OFFICE	1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	1
FUNDACION CIDETEC	1
IBM RESEARCH	1
INGENIATRICS TECNOLOGIAS SL	1
INSERM TRANSFERT	1
MICROFLUIDIC CHIPSHOP	1
PATHOFINDER HOLDING BV	1
SETLANCE	1
UMAPS COMMUNICATION SARL	1
UNIVERSITEIT ANTWERPEN	1
UNIVERSITEIT UTRECHT	1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2015-04-01	Early diagnosis of cervical cancer through the validation of Human Papilloma Virus viral load and expression of oncogenic viral proteins E6/E7 as risk indicators	SixthSense	coordinator	50.000	1
2014-01-01	Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia Infections	PNEUMONP	participant	5.682.351	11
2012-01-01	Chips for Life	C4L	participant	2.876.300	8

Alias institution names:

PATHOFINDER B V